V
Vital Bio
Biotech & Life Sciences · Mississauga, Canada · Founded 2018
Point-of-care blood testing for rapid diagnostic results MoreLess
Vital Bio, also known as Vital Biosciences Inc., is a Canadian health-tech company founded in 2019 by Vasu Nadella, Mounir Koussa, Farnoud Kazemzadeh, Iman Khodadad, and Dr. Emily Chen. The company is headquartered in Toronto, Canada, and operates in the laboratory services and diagnostics sector. Co-founder Mounir Koussa developed core technology for the company from his previous startup, Confer Health, which he spun out of his PhD at Harvard.
Vital Bio is developing the "VitalOne," a desktop-sized, automated platform designed to bring comprehensive lab testing to point-of-care settings like primary care clinics, pharmacies, and in-home care locations. The device uses 600 microliters of blood to perform over 50 lab-grade tests, covering approximately 95% of routine lab orders. By leveraging advancements in microfluidics, robotics, computer vision, and biochemistry, the VitalOne runs hematology, clinical chemistry, and immunoassay tests in parallel, delivering results in about 20 minutes. This allows medical professionals to test, diagnose, and treat patients within a single visit. The system is designed for ease of use, with less than 30 seconds of hands-on time, and includes features like a patient app for result tracking.
The company's business model aims to disrupt the diagnostics industry by making testing more accessible and reducing delays in patient care. Vital Bio is privately held and has secured significant funding to support its growth and product development. As of July 2023, the company had raised a total of $48 million from investors including Lachy Groom, Northpond Ventures, Labcorp, Inovia Capital, and notable individuals like Sam Altman and Marc Benioff. A Series B funding round in September 2024 brought the total raised to over $62 million.
Keywords: point-of-care diagnostics, blood testing platform, lab-grade results, medical diagnostics, VitalOne, hematology, clinical chemistry, immunoassays, health technology, preventative healthcare, microfluidics, Vasu Nadella, Mounir Koussa, point-of-care testing, rapid diagnostics, diagnostic device, healthcare accessibility, in-home care testing, primary care diagnostics, mobile health, diagnostic robotics
Company overview
Vital Bio company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2018
- Headquarters
- Mississauga, Canada
- Employees
- 251
- Open positions
- None listed
- Dealroom signal
- 88.5
Valuation & funding
Vital Bio funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Jul 2023 | $48M | $192M | Inovia Capital · LabCorp · Marc Benioff · Sam Altman | ↗ |
| SEEDEquity / VC | Apr 2019 | $0 | — | Undisclosed | — |
| SPINOUT✓Other financing | Dec 2018 | $0 | — | University of Waterloo · Harvard University | — |
| SUPPORT PROGRAM✓Other financing | Dec 2018 | $0 | — | Rogers Cybersecure Catalyst | — |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 278 |
| 2025 | 220 |
| 2024 | 149 |
Growth signals
Vital Bio website traffic
Latest recorded traffic for Vital Bio is 11K monthly website visits, down 26.7% over the last three months. Vital Bio's team grew 14.1% over the past year.
Comparisons
Vital Bio compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Vital Bio's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Vital Bio has talent and traffic
team presence
In the news
Latest news about Vital Bio
Recent press, funding announcements, and product moves mentioning Vital Bio — open to read from the original sources.
Market sentiment
What the market is saying about Vital Bio
An AI-synthesized read of the highest-engagement posts about Vital Bio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Vital Bio’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.